Fine Foods & Pharmaceuticals N.T.M Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 4/6

Fine Foods & Pharmaceuticals N.T.M has a total shareholder equity of €128.4M and total debt of €61.5M, which brings its debt-to-equity ratio to 47.9%. Its total assets and total liabilities are €239.8M and €111.4M respectively. Fine Foods & Pharmaceuticals N.T.M's EBIT is €9.8M making its interest coverage ratio 2.4. It has cash and short-term investments of €15.2M.

Anahtar bilgiler

47.9%

Borç/özkaynak oranı

€61.53m

Borç

Faiz karşılama oranı	2.4x
Nakit	€15.21m
Eşitlik	€128.40m
Toplam yükümlülükler	€111.41m
Toplam varlıklar	€239.81m

Son finansal sağlık güncellemeleri

Is Fine Foods & Pharmaceuticals N.T.M (BIT:FF) Using Too Much Debt?

Dec 08

Recent updates

Solid Earnings Reflect Fine Foods & Pharmaceuticals N.T.M's (BIT:FF) Strength As A Business

Sep 20

Is There An Opportunity With Fine Foods & Pharmaceuticals N.T.M. S.p.A.'s (BIT:FF) 40% Undervaluation?

Apr 28

Estimating The Fair Value Of Fine Foods & Pharmaceuticals N.T.M. S.p.A. (BIT:FF)

Mar 20

Something To Consider Before Buying Fine Foods & Pharmaceuticals N.T.M. S.p.A. (BIT:FF) For The 1.1% Dividend

Feb 22

A Look At Fine Foods & Pharmaceuticals N.T.M's (BIT:FF) Share Price Returns

Feb 01

What You Need To Know About Fine Foods & Pharmaceuticals N.T.M. S.p.A.'s (BIT:FF) Investor Composition

Jan 14

We Wouldn't Rely On Fine Foods & Pharmaceuticals N.T.M's (BIT:FF) Statutory Earnings As A Guide

Dec 28

Is Fine Foods & Pharmaceuticals N.T.M (BIT:FF) Using Too Much Debt?

Dec 08

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: FF's short term assets (€106.4M) exceed its short term liabilities (€67.6M).

Uzun Vadeli Yükümlülükler: FF's short term assets (€106.4M) exceed its long term liabilities (€43.8M).

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: FF's net debt to equity ratio (36.1%) is considered satisfactory.

Borcun Azaltılması: FF's debt to equity ratio has increased from 21.4% to 47.9% over the past 5 years.

Borç Kapsamı: FF's debt is well covered by operating cash flow (64.9%).

Faiz Kapsamı: FF's interest payments on its debt are not well covered by EBIT (2.4x coverage).

Fine Foods & Pharmaceuticals N.T.M Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 4/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Is Fine Foods & Pharmaceuticals N.T.M (BIT:FF) Using Too Much Debt?

Recent updates

Solid Earnings Reflect Fine Foods & Pharmaceuticals N.T.M's (BIT:FF) Strength As A Business

Second quarter 2024 earnings released

Now 20% undervalued

Upcoming dividend of €0.12 per share

First quarter 2024 earnings released

Now 20% undervalued after recent price drop

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Third quarter 2023 earnings released

Second quarter 2023 earnings released

New major risk - Revenue and earnings growth

Fine Foods & Pharmaceuticals N.T.M. S.p.A. (BIT:FF) commences an Equity Buyback Plan for 20% of its issued share capital,under the authorization approved on May 9, 2023.

First quarter 2023 earnings released

Upcoming dividend of €0.10 per share at 1.3% yield

Less than half of directors are independent

Consensus forecasts updated

Price target decreased to €11.50

Second quarter 2022 earnings released

First quarter 2022 earnings: Revenues in line with analyst expectations

Upcoming dividend of €0.16 per share

Is There An Opportunity With Fine Foods & Pharmaceuticals N.T.M. S.p.A.'s (BIT:FF) 40% Undervaluation?

Price target decreased to €14.25

Less than half of directors are independent

Full year 2021 earnings: EPS misses analyst expectations

Now 30% undervalued after recent price drop

Fine Foods & Pharmaceuticals N.T.M. S.p.A. (BIT:FF) made an offer to acquire an additional 24.94% stake in Euro Cosmetic Spa (BIT:EC) for €10.2 million.

Price target decreased to €20.50

Third quarter 2021 earnings released

Fine Foods & Pharmaceuticals N.T.M. S.p.A. (BIT:FF) signed a binding agreement to acquire a 72.9% stake in Euro Cosmetic S.p.A. (BIT:EC) from Findea's Srl and MD S.R.L. for €26.8 million.

First half 2021 earnings released: €0.26 loss per share

Price target increased to €18.50

Upcoming dividend of €0.14 per share

Full year 2020 earnings released: EPS €0.58 (vs €0.12 loss in FY 2019)

Price target increased to €15.50

Price target increased to €14.90

Consensus EPS estimates fall to €0.52

Full year 2020 earnings released: EPS €0.58 (vs €0.34 in FY 2019)

Estimating The Fair Value Of Fine Foods & Pharmaceuticals N.T.M. S.p.A. (BIT:FF)

Fine Foods & Pharmaceuticals N.T.M. S.p.A. to Report Fiscal Year 2020 Results on Apr 12, 2021

Something To Consider Before Buying Fine Foods & Pharmaceuticals N.T.M. S.p.A. (BIT:FF) For The 1.1% Dividend

A Look At Fine Foods & Pharmaceuticals N.T.M's (BIT:FF) Share Price Returns

What You Need To Know About Fine Foods & Pharmaceuticals N.T.M. S.p.A.'s (BIT:FF) Investor Composition

We Wouldn't Rely On Fine Foods & Pharmaceuticals N.T.M's (BIT:FF) Statutory Earnings As A Guide

Price target raised to €13.50

Is Fine Foods & Pharmaceuticals N.T.M (BIT:FF) Using Too Much Debt?

New 90-day high: €11.30

New 90-day low: €9.76

First half earnings released

New 90-day low: €10.45

New 90-day high - €11.10

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Sağlıklı şirketleri keşfedin